In Reply We thank Schatman et al for their comments in response to our Original Investigation on the frequency of and factors associated with nonmedical opioid use (NMOU) behavior among patients with cancer receiving opioids for cancer pain.1 In this study, we found that the frequency of NMOU behavior in patients with cancer taking prescribed opioids was 19%; the most frequent NMOU behavior observed, unscheduled clinic visits for inappropriate refills, was 49%. Other frequent NMOU behaviors were self-escalation of opioid dosage not consistent with patient’s pain syndrome (17%), use of nonprescribed restricted medications or illicit drugs (13%), and reports of impaired functioning in daily activities due to opioid use (15%).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Yennurajalingam S, Bruera E. Questionable Conceptualizations of Nonmedical Use Can Contribute to Needless Distress—Reply. JAMA Oncol. 2021;7(6):942–943. doi:10.1001/jamaoncol.2021.0572
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.